Hepatocellular carcinoma: Current situation and challenge
Publication date: Available online 11 June 2019Source: Hepatobiliary & Pancreatic Diseases InternationalAuthor(s): Zhao Li, Ji-Ye Zhu (Source: Hepatobiliary and Pancreatic Diseases International)
Source: Hepatobiliary and Pancreatic Diseases International - June 26, 2019 Category: Gastroenterology Source Type: research

Individualized and pancreatic duct diameter-based strategy for pancreaticoenteric anastomosis during pancreaticoduodenectomy
ConclusionsThe individual strategy based on the pancreatic duct diameter might effectively reduce the incidence of postoperative pancreatic fistula and other severe complications of PD. HBPG anastomosis is suitable for patients with pancreatic duct smaller than 3 mm. The size of the pancreatic duct is also one of the considerations for the selection of pancreatic and enteric duct anastomosis. (Source: Hepatobiliary and Pancreatic Diseases International)
Source: Hepatobiliary and Pancreatic Diseases International - June 26, 2019 Category: Gastroenterology Source Type: research

Diagnostic role of microRNA-125b for hepatocellular carcinoma
Publication date: Available online 26 June 2019Source: Hepatobiliary & Pancreatic Diseases InternationalAuthor(s): Feng Li, Quan-Wa Bao, Liu-Yi-Qi Jiang, Qi-Lin Huang, Xu Zhang, Ju-Xiang Chen (Source: Hepatobiliary and Pancreatic Diseases International)
Source: Hepatobiliary and Pancreatic Diseases International - June 26, 2019 Category: Gastroenterology Source Type: research

Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition)
Publication date: Available online 26 June 2019Source: Hepatobiliary & Pancreatic Diseases InternationalAuthor(s): Xiao Xu, Jun Chen, Qiang Wei, Zhi-Kun Liu, Zhe Yang, Ming Zhang, Guo-Ying Wang, Jie Gao, Zhao-Xu Yang, Wen-Yuan Guo, Tong-Hai Xing, Zhou Shao, Qin-Fen Xie, Shu-Sen Zheng (Source: Hepatobiliary and Pancreatic Diseases International)
Source: Hepatobiliary and Pancreatic Diseases International - June 26, 2019 Category: Gastroenterology Source Type: research

Prediction of survival after left-sided pancreatic resection for adenocarcinoma: Introduction of a new prognostic score
ConclusionsThe 18-month mortality risk for patients after left-sided pancreatectomy for adenocarcinoma of the pancreatic body can be assessed with the number of intra-operatively transfused packed red blood cells, elevated CA 19-9 levels, additional gastric resection and prior abdominal surgeries in the patient's history. (Source: Hepatobiliary and Pancreatic Diseases International)
Source: Hepatobiliary and Pancreatic Diseases International - June 26, 2019 Category: Gastroenterology Source Type: research